Opendata, web and dolomites

SAL ETHVI

Innovative, easily applicable vaccine for poultry industry against five Salmonella serovars: Enteritidis, Typhimurium, Hadar, Virchow and Infantis – SAL ETHVI

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SAL ETHVI project word cloud

Explore the words cloud of the SAL ETHVI project. It provides you a very rough idea of what is the project "SAL ETHVI" about.

meat    chickens    owners    human    infantis    price    activation    critical    reduce    worldwide    disease    flocks    frequently    humans    industry    poisoning    united    complete    feasibility    market    despite    hadar    vaccine    germany    places    vaccines    risk    russia    immunolab    serovar    certification    mapping    virchow    constituting    hens    innovative    food    serovars    ethvi    comprise    registration    poland    ultimately    markets    producers    biggest    patent    instrument    breakthrough    safer    78    vaccination    business    gastrointestinal    listed    serotypes    plan    spreading    typhimurium    enteritidis    risks    contaminated    commercialize    chain    sal    farms    france    rates    performed    sme    breeders    levels    poultry    netherlands    biosecurity    configuration    lower    sources    hatching    strategy    adventage    intervention    broilers    species    filled    chicken    pathogens    sizing    competitive    salmonella    kingdom    2003    infections    invented    zoonotic    animals    bacteria   

Project "SAL ETHVI" data sheet

The following table provides information about the project.

Coordinator
ZAKLAD BADAWCZO-WDROZENIOWY OSRODKASALMONELLA IMMUNOLAB SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA 

Organization address
address: UL. AL. ZWYCIESTWA 96/98
city: GDYNIA
postcode: 81 451
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Poland [PL]
 Project website http://immunolab.com.pl/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.3.2. (SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2016-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ZAKLAD BADAWCZO-WDROZENIOWY OSRODKASALMONELLA IMMUNOLAB SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA PL (GDYNIA) coordinator 50˙000.00
2    NatVet sp. z o. o. PL (Gdansk) participant 0.00

Map

 Project objective

Salmonella species (also called serovars) are important zoonotic pathogens that cause gastrointestinal disease in humans and animals. Poultry products contaminated with these pathogens are one of the major sources of human Salmonella infections worldwide. Salmonella Enteritidis and Typhimurium are the serovars most frequently associated with human food poisoning (78.3 % of all cases in 2003). The serovars of Salmonella having places three to five are Virchow, Infantis and Hadar. Vaccination of chickens, along with other intervention measures in the overall biosecurity system of chicken farms, is an important strategy that is currently being used to reduce the levels of Salmonella in poultry flocks, which will ultimately lead to lower rates of human infections. However, despite numerous studies that have been performed, there is still a need for safer, well-defined Salmonella vaccines. At Immunolab we invented SAL ETHVI – innovative vaccine against above listed 5 serovars of Salmonella. We also breakthrough the technology for the vaccine production in a way that allows any configuration of serotypes, therefore if there is a need for a vaccine against another serovar, its production will be very easy. The end users of the vaccine will be poultry breeders, namely hens and broilers flocks owners. The unique features of our vaccine constituting our competitive adventage comprise : (1) easy application ; (2) low price ; (3) immediate vaccination upon hatching; (4) no risk of bacteria activation and spreading. We have filled a patent application for the technology and upon the vaccine registration and certification, we aim to commercialize it at the broilers markets of the biggest European poultry meat producers: Poland, Germany, France, the Netherlands, United Kingdom and Russia. We are applying for the SME Instrument Phase 1, aiming to complete the feasibility study and a business plan including industry value-chain mapping, market sizing and critical risks assessment.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SAL ETHVI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SAL ETHVI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.3.2.)

SCHOCKO3 (2015)

Novel Ozone and Thermal Shock Conservation Process for Vegetables

Read More  

UVT (2015)

UV cleaning for beverage tanks eliminating the need for water and chemicals

Read More  

VIOTRAP (2015)

Elaboration of an Innovative Eco-Friendly Pest Control Method in European Agriculture

Read More